The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 30, 2025

Filed:

Sep. 16, 2022
Applicant:

The Chinese University of Hong Kong, Hong Kong, CN;

Inventors:

Yangzi Jiang, Hong Kong, CN;

Xiaobo Zhu, Hong Kong, CN;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/16 (2006.01); A61K 9/50 (2006.01); A61K 31/4418 (2006.01);
U.S. Cl.
CPC ...
A61K 9/1694 (2013.01); A61K 9/1647 (2013.01); A61K 9/5031 (2013.01); A61K 9/5089 (2013.01); A61K 31/4418 (2013.01);
Abstract

A therapeutic sustained delivery vehicle (TSDV) includes a plurality of microparticles with pirfenidone (PFD) within a poly(lactic-co-glycolic acid) (PLGA) matrix, where the microparticles are suspended in a hyaluronic acid (HA) solution. This suspension of microparticles are useful for injection into a joint that suffers from osteoarthritis (OA) inflammation and pain. The microparticles are microspheres formed by forming a solution of PDF and PLGA in a water insoluble organic solvent that is emulsified with an aqueous solution. Upon evaporation of the organic solvent the resulting microspheres are separated from the suspension. The microspheres are suspended in a HA solution. An OA treatment is a periodic injection protocol that provides a long-term in vivo controlled-release PFD to modulate and attenuate the OA progression.


Find Patent Forward Citations

Loading…